VirTrial has acquired fellow telemedicine platform developer SnapMD, which had raised about $16m from investors including Shea Ventures.
Real estate developer JF Shea has exited US-based telemedicine tool developer SnapMD through an acquisition of undisclosed size by telemedicine services provider VirTrial.
SnapMD has built a cloud software platform that enables healthcare providers to communicate with and treat patients remotely. VirTrial plans to add elements of the company’s offering to its own Virtual Care Management (VCM) platform.
VirTrial chief executive Mark Hanley said: “Our acquisition of SnapMD enables us to better implement our vision of making clinical trials easier…
